CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Transversus abdominus plane block +1 moredrug
Likely dose
Transversus abdominus plane block 40 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04623632
NCT04623632Phase 2Completed

Effect of the Modified Surgeon Assisted Bilateral TAP Block on Time Required for First Analgesic Dose After Cesarean Section Under Spinal Anesthesia:A Randomized,Placebo-controlled, Double Blinded Clinical Trial

Ain Shams Maternity Hospital·interventional·Posted Nov 10, 2020·Updated Dec 23, 2022

In Brief

A Phase 2 clinical trial evaluating Transversus abdominus plane block and Transversus abdominus plane placebo for Postoperative Pain. Completed, enrolled 60 participants across 1 site.

Detailed Summary

While opioids are the mainstay for post-operative analgesia after caesarean section, they are associated with various side effects. Ultrasound guided transversusabdominis plane (TAP) block has been postulated to provide effective analgesia for caesarean section. However a new technique in TAP block is described which can be used safely by a beginner without any fear of complication whichwill help in providing good postoperative analgesia to maximumnumber of patients. This study will evaluate the analgesic efficacy of TAP block using Modified Surgeon Assisted Bilateral TAP block for post caesarean analgesia in a randomized controlled trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

Phase 2CompletedFinished
202120222023202420252026
First PostedNov 10, 2020
Enrollment StartSep 20, 2020
Primary CompletionMar 20, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 5.6 years ago

Interventions

Transversus abdominus plane blockdrug

transversus abdominus plane block using 40 ml of bupivacaine 0.25%

Transversus abdominus plane placebodrug

injection of 40 ml of normal saline in the transversus abdominus plane